No Data
No Data
Easy-To-Trade Cannabis Stocks: Insights Into How Trading Activity Affects These Investments
The trading volume of a stock reflects the number of shares bought and sold within a given time. This is called liquidity. The term is used because it likens the ease of converting assets to cash to t
Cannabis Rescheduling: When Will It Happen? Expert Lays Out Timeline, Risks And Wild Cards
The Department of Justice (DOJ) confirmed that it has started the formal rulemaking process to reclassify cannabis to Schedule III. This significant step reinforces the positive outlook for cannabis s
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). This shift could revolutionize the cannabis industry. B
Cannabis Stock Movers For May 17, 2024
GAINERS:Elixinol Wellness (OTC:ELLXF) shares closed up 116.00% at $0.01CordovaCann (OTC:LVRLF) shares closed up 29.04% at $0.07Heritage Cannabis Holding (OTC:HERTF) shares closed up 25.00% at $0.00Cha
Tilray Brands Shares Are Trading Lower After the Company Announced an At-the-market Program to Fund Acquisitions.
Tilray Brands Shares Are Trading Lower After the Company Announced an At-the-market Program to Fund Acquisitions.
AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
Cantor Fitzgerald has initiated coverage on AbbVie Inc (NYSE:ABBV), a global pharma company.The analyst notes that the company has positioned itself to absorb Humira biosimilar erosion and achieve mod